0001656472-24-000037.txt : 20240319
0001656472-24-000037.hdr.sgml : 20240319
20240319170220
ACCESSION NUMBER: 0001656472-24-000037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GORENSTEIN MICHAEL RYAN
CENTRAL INDEX KEY: 0001797199
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38403
FILM NUMBER: 24764773
MAIL ADDRESS:
STREET 1: 111 PETER STREET, SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cronos Group Inc.
CENTRAL INDEX KEY: 0001656472
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 PETER STREET
STREET 2: SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
BUSINESS PHONE: (416) 504-0004
MAIL ADDRESS:
STREET 1: 111 PETER STREET
STREET 2: SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaCan Capital Corp.
DATE OF NAME CHANGE: 20151021
4
1
wk-form4_1710882126.xml
FORM 4
X0508
4
2024-03-15
0
0001656472
Cronos Group Inc.
CRON
0001797199
GORENSTEIN MICHAEL RYAN
111 PETER STREET, SUITE 300
TORONTO
A6
M5V 2H1
ONTARIO, CANADA
1
1
0
0
See remarks below
0
COMMON SHARES
2024-03-15
4
M
0
31361
0
A
9859538
D
COMMON SHARES
2024-03-15
4
F
0
7636
1.98
D
9851902
D
COMMON SHARES
2024-03-15
4
M
0
324539
0
A
10176441
D
COMMON SHARES
2024-03-15
4
F
0
79025
1.98
D
10097416
D
RESTRICTED STOCK UNITS
2024-03-15
4
M
0
31361
0
D
COMMON SHARES
31361
5321715
D
RESTRICTED STOCK UNITS
2024-03-15
4
M
0
324539
0
D
COMMON SHARES
324539
4997176
D
Each restricted stock unit ("RSU") represents a contingent right to receive one common share of Cronos Group Inc.
On August 5, 2022, the reporting person was granted 94,083 RSUs, vesting in three substantially equal installments on each of March 15, 2023, March 15, 2024 and March 15, 2025.
On March 15, 2023, the reporting person was granted 973,618 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
Chairman, Chief Executive Officer, and President
/s/ Aaron Werner, as attorney-in-fact for Michael R. Gorenstein
2024-03-19